News for 'covid-19 variant'

Omicron risk remains 'very high', says WHO

Omicron risk remains 'very high', says WHO

Rediff.com29 Dec 2021

The weekly epidemiological update by WHO revealed the week of December 20-26 saw the global number of new COVID-19 cases increase by 11 per cent as compared to the previous week.

Centre, states ramp up efforts to avert a BF.7 outbreak

Centre, states ramp up efforts to avert a BF.7 outbreak

Rediff.com23 Dec 2022

Amid growing concerns over the spurt in COVID-19 cases in China and some other countries, Health Minister Mansukh Mandaviya said the focus is to ensure that no unknown variant of the virus enters India and at the same time there is no impediment to travelling.

Omicron may be dominant strain globally in 2022, claim Singapore experts

Omicron may be dominant strain globally in 2022, claim Singapore experts

Rediff.com24 Dec 2021

The new and highly transmissible Omicron variant of the deadly coronavirus has increased immune escape compared with the Delta variant and appears likely to become the dominant SARS-CoV-2 strain globally in 2022, according to Singapore-based experts.

Covid 4th wave possible in June, warns IIT-Kanpur study

Covid 4th wave possible in June, warns IIT-Kanpur study

Rediff.com28 Feb 2022

The fourth wave of the Covid-19 pandemic in India may start around June 22 and peak from mid to late August, a modelling study by researchers at the Indian Institute of Technology-Kanpur suggests.

High-level meet stresses on Covid-appropriate behaviour at all times

High-level meet stresses on Covid-appropriate behaviour at all times

Rediff.com27 Mar 2023

Amid a spike in Covid-19 cases, the Centre on Monday reviewed with states and Union territories the preparedness for pandemic management and the progress of vaccination.

Covaxin effective against Delta Plus: ICMR study

Covaxin effective against Delta Plus: ICMR study

Rediff.com2 Aug 2021

Covaxin, a whole-virion inactivated SARS-CoV-2 vaccine used for mass immunization in the country, showed a 65.2 per cent protection against the Delta variant in a double-blind, randomized, multicentre, phase 3 clinical trial.

Omicron scare: SII seeks approval for Covishield booster

Omicron scare: SII seeks approval for Covishield booster

Rediff.com2 Dec 2021

The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.

Covid spurt: Karnataka to screen international passengers

Covid spurt: Karnataka to screen international passengers

Rediff.com21 Dec 2022

The minister emphasised the need for people to take precaution dose of COVID-19 vaccine amid a surge in COVID-19 cases in some parts of the world, especially in China.

'Even if a third wave comes, we must keep it to a ripple rather let it surge to a tidal wave'

'Even if a third wave comes, we must keep it to a ripple rather let it surge to a tidal wave'

Rediff.com16 Jun 2021

'A third wave is possible, but we must try to restrict it to a low level by adopting all personal protection and public policy measures to prevent viral transmission, while speeding up vaccination.'

Experts downplay apprehensions centred around Covid XE

Experts downplay apprehensions centred around Covid XE

Rediff.com7 Apr 2022

Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.

Amid global pressure, China says Covid data transparent

Amid global pressure, China says Covid data transparent

Rediff.com1 Jan 2023

"China has always been publishing information on COVID-19 deaths and severe cases in the spirit of openness and transparency," Jiao Yahui, head of the Bureau of Medical Administration under the National Health Commission, said at a press briefing held.

No scientific evidence Mumbai case is Covid XE: Central experts

No scientific evidence Mumbai case is Covid XE: Central experts

Rediff.com6 Apr 2022

INSACOG experts are conducting genomic analysis of a coronavirus case reported as that of the highly transmissible XE variant by Mumbai civic officials, though scientific evidence so far does not indicate it to be so, official sources said on Wednesday.

China faces 'new Covid situation': Xi Jinping

China faces 'new Covid situation': Xi Jinping

Rediff.com26 Dec 2022

In his fresh directive, Xi said that more targeted patriotic health campaigns should be conducted as the country's COVID-19 epidemic prevention and control faces new situations and new tasks.

Covid 3rd wave peak likely in Oct: NIDM report tells PMO

Covid 3rd wave peak likely in Oct: NIDM report tells PMO

Rediff.com23 Aug 2021

Emphasising the effect of the potential COVID third wave on children, the report said the Indian Academy of Paediatrics found that there is no biological evidence that the current and the new Delta Plus variant will affect children more than adults.

2nd COVID wave poses downside risks to India's economic growth: S&P

2nd COVID wave poses downside risks to India's economic growth: S&P

Rediff.com28 Apr 2021

S&P Global Ratings on Wednesday said the second wave of COVID infections poses downside risks to India's GDP and heightens the possibility of business disruptions. The second wave brings in uncertainty and a drawn-out COVID outbreak will impede India's recovery, it said.

Pfizer, AstraZeneca vaccines less effective against Delta

Pfizer, AstraZeneca vaccines less effective against Delta

Rediff.com19 Aug 2021

The researchers analysed 2580,021 test results from nose and throat swabs taken from 384,543 participants aged 18 years or older between December 1, 2020 and May 16, 2021.

Mock drill across India on Dec 27 to check Covid preparedness

Mock drill across India on Dec 27 to check Covid preparedness

Rediff.com23 Dec 2022

During a virtual meeting with health ministers and senior officials of states in view of the recent surge in coronavirus cases in some parts of the world, he said, "The Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for Covid prevention and management."

2021: How Covid kept the world on tenterhooks, with surprises aplenty

2021: How Covid kept the world on tenterhooks, with surprises aplenty

Rediff.com29 Dec 2021

As the Omicron strain spreads across the globe and questions on vaccine inequity dominate discussions, scientists are still scrambling to learn more about emerging variants of the deadly virus that has claimed millions of lives and crippled economies.

'Unscientific to consider 2 doses as full vaccination'

'Unscientific to consider 2 doses as full vaccination'

Rediff.com26 Apr 2022

'If a fourth wave comes it will be a total surprise to me'

Modi's visit to UAE postponed amid Omicron surge

Modi's visit to UAE postponed amid Omicron surge

Rediff.com29 Dec 2021

Prime Minister Narendra Modi's planned visit to the United Arab Emirates in the first half of next month has been postponed, people familiar with the development said.

Doctors advise caution as Covid positivity rate rises

Doctors advise caution as Covid positivity rate rises

Rediff.com12 Apr 2022

People must be vigilant, follow all safety norms and not let a sense of complacency set in, several doctors said a day after the positivity rate in the city was --- the highest in two months.

China warns of countermeasures for Covid curbs on its travellers abroad

China warns of countermeasures for Covid curbs on its travellers abroad

Rediff.com3 Jan 2023

Foreign ministry spokesperson Mao Ning went on the offensive saying "we do not believe the entry restriction measures some countries have taken against China are science-based".

WHO again asks China to regularly share real-time data on Covid situation

WHO again asks China to regularly share real-time data on Covid situation

Rediff.com31 Dec 2022

The global health agency has asked Chinese health officials to share data on genetic sequencing, hospitalisations, deaths and vaccinations.

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Rediff.com31 Dec 2021

"In children, fortunately, infections with SARS-CoV-2 are generally not severe. There is a risk of long COVID, there is a risk of a very, very rare condition called MISC (Multisystem Inflammatory Syndrome) but by and large healthy children have nothing," said Dr Gagandeep Kang, leading Indian virologist.

Sitharaman reviews PSBs' readiness to tackle any Omicron-induced disruption

Sitharaman reviews PSBs' readiness to tackle any Omicron-induced disruption

Rediff.com7 Jan 2022

Finance Minister Nirmala Sitharaman on Friday chaired a meeting with chiefs of public sector banks and assessed their readiness to tackle any possible disruptions due to the Omicron variant. In a tweet, the finance ministry said during the meeting with CMDs/MDs, held through virtual mode, the minister also reviewed various steps taken by PSBs in implementing pandemic-related measures initiated by the government and RBI.

Most Indians may be safe against Omicron, no need for panic: Dr Jameel

Most Indians may be safe against Omicron, no need for panic: Dr Jameel

Rediff.com30 Nov 2021

A 'very large' number of Indians are likely to remain protected from Omicron or any other variant of COVID-19 and there is no need to panic, eminent virologist Dr Shahid Jameel has said.

UK opens up COVID boosters to all over 30s in Omicron fight

UK opens up COVID boosters to all over 30s in Omicron fight

Rediff.com12 Dec 2021

There are around 7.5 million people aged 30 to 39, and 3.5 million of those are eligible for boosters from Monday, NHS England said.

Covid 3rd wave likely this month, may peak in Oct: Report

Covid 3rd wave likely this month, may peak in Oct: Report

Rediff.com2 Aug 2021

The next wave is likely to be far smaller than the second wave that peaked at a record 400,000-plus daily cases on May 7 and declined sharply thereafter.

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Rediff.com2 Mar 2022

Antibodies produced by two doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study that highlights the importance of a booster dose.

Maha, Kerala, K'taka log more Omicron cases; India's tally rises to 126

Maha, Kerala, K'taka log more Omicron cases; India's tally rises to 126

Rediff.com18 Dec 2021

The Centre has warned it is likely that the spread of the new variant will outpace the Delta variant where there is community transmission.

Covaxin 50% effective against symptomatic Covid: Lancet

Covaxin 50% effective against symptomatic Covid: Lancet

Rediff.com24 Nov 2021

Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.

COVID: 'India is safe for the present'

COVID: 'India is safe for the present'

Rediff.com23 Dec 2022

'Viral infections rise in winter and better care needs to be taken in the next few months.'

Omicron subvariant BA.2 spreads faster, may cause severe disease: Study

Omicron subvariant BA.2 spreads faster, may cause severe disease: Study

Rediff.com18 Feb 2022

The yet-to-be peer-reviewed findings, recently posted on the preprint repository BioRxiv, show that the BA.2 sub variant may have features that make it as capable of causing serious illness as older coronavirus variants.

Omicron adds new uncertainties to global economic outlook: Moody's

Omicron adds new uncertainties to global economic outlook: Moody's

Rediff.com29 Nov 2021

The Omicron variant of Covid-19 adds new uncertainties to the global economic outlook but much will depend on its speed of transmission, hospitalisation and death rates, and also the effectiveness of vaccines, Moody's Analytics said on Monday. In its commentary titled 'Much to Learn About Omicronast', Moody's Analytics said although the variant appears to spread "remarkably quickly", it will be at least two more weeks before more will be known about this new variant. "The Omicron variant of COVID-19 adds new measures of uncertainty to the outlook for the global economy, although it is too soon to adequately quantify that risk.

21 Photos That Defined 2021

21 Photos That Defined 2021

Rediff.com1 Jan 2022

Images that capture what it was like living through 2021.

402 Parl staff test Covid positive ahead of budget session

402 Parl staff test Covid positive ahead of budget session

Rediff.com9 Jan 2022

Ahead of the budget session of Parliament, more than 400 Parliament staff members tested positive for COVID-19, according to official sources.

Covid scare: Centre asks states to ensure mask use, booster coverage

Covid scare: Centre asks states to ensure mask use, booster coverage

Rediff.com22 Dec 2022

The health minister said states have also been advised to increase the whole genome sequencing of all positive cases for timely detection of newer variants, if any.

US reports first case of Omicron

US reports first case of Omicron

Rediff.com2 Dec 2021

The case has been detected in the US state of California, Top Medical Adviser Anthony Fauci was quoted as saying by CNN.

Mpox Puts Health System On High Alert

Mpox Puts Health System On High Alert

Rediff.com17 Aug 2024

Strict screening protocols are to be implemented for passengers arriving from central African countries affected by the outbreak.

'Remember, always, the virus doesn't want to die'

'Remember, always, the virus doesn't want to die'

Rediff.com31 Dec 2021

'If you think you think you're going to booster yourself out of the pandemic, in COVID-19's case, you can forget it.'